Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies. Highlights of the Company’s pipeline include a menin inhibitor for R/R acute leukemia and a monoclonal antibody that blocks the CSF-1 receptor for chronic graft-versus-host disease. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment.
Review our social media community guidelines below:
https://syndax.com/social-media-community-guidelines/
Company Details
- Employees
- 339
- Address
- 730 3rd Ave,
- Phone
- (185) 879-2799
- in****@****dax.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- syndax.com
- HQ
- New York, NY
Syndax Pharmaceuticals Questions
Syndax Pharmaceuticals's helpline number is (185) 879-2799
Syndax Pharmaceuticals's website is syndax.com
Syndax Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/syndax-pharmaceuticals
Syndax Pharmaceuticals has
339 employees.
View email and phone details for 339
employees at Syndax Pharmaceuticals.
Syndax Pharmaceuticals's industry is
Biotechnology Research
Syndax Pharmaceuticals's top competitors are
Alnylam Pharmaceuticals,
Agios Pharmaceuticals,
Kura Oncology, Inc.,
Jazz Pharmaceuticals,
Vertex Pharmaceuticals,
Incyte,
Madrigal Pharmaceuticals,
Ionis Pharmaceuticals, Inc.,
Sage Therapeutics,
Acadia Pharmaceuticals Inc..
Syndax Pharmaceuticals's support email address is info@syndax.com
Syndax Pharmaceuticals's categories are Biotechnology Research
